AFP and hepatocellular carcinoma: The serum levels of AFP and AFP‐L3% were evaluated in all of included subjects; and 6 of these 16 studies which included 756 HCC patients and 1087 controls were further assessed the performance of AFP + AFP‐L3% in HCC diagnosing (Table 1).